Pregled bibliografske jedinice broj: 160430
Post-exposure Prophylaxis of HIV infection in healthcare workers: Recommendation for the European setting
Post-exposure Prophylaxis of HIV infection in healthcare workers: Recommendation for the European setting // European journal of epidemiology, 19 (2004), 6; 577-84 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 160430 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Post-exposure Prophylaxis of HIV infection in healthcare workers: Recommendation for the European setting
Autori
Puro, Vincenzo ; Cicalini, Stefania ; De Carli, Gabriella ; Soldani, Fabio ; Antunes, Francisco ; Balslev, Ulla ; Begovac, Josip ; Bernasconi, Enos ; Boaventura, José L. ; Campins Martí, Magda ; Čivljak, Rok ; Evans, Barry ; Francioli, Patrick ; Genasi, Fiona ; Larsen, Christine ; Lot, Florence ; Lunding, Suzanne ; Marcus, Ulrich ; Pereira, Alvaro A. ; Thomas, Tania ; Schonwald, Slavko ; Ippolito, Giuseppe
Izvornik
European journal of epidemiology (0393-2990) 19
(2004), 6;
577-84
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
antiretrovirals; healthcare workers; HIV; occupational exposure; post-exposure prophylaxis
Sažetak
The European Commission funded a project for the standardisation of the management of occupational exposures to HIV/blood-borne infections and antiretroviral post-exposure prophylaxis (PEP) in Europe. Within this project, the following recommendations and rationale were formulated by experts representative of participating countries. Based on assessment of the exposure, material, and source characteristics, PEP should be started as soon as possible with any triple combination of antiretrovirals approved for the treatment of HIV-infected patients ; initiation is discouraged after 72 hours Rapid HIV testing of the source could reduce inappropriate PEP. HIV testing should be performed at baseline, 4, 12, and 24 weeks, with additional clinical and laboratory monitoring of adverse reactions and potential toxicity at week 1 and 2. HIV resistance tests in the source and direct virus assays in the exposed HCW are not recommended routinely. These easy-to-use recommendations seek to maximise PEP effect while minimising its toxicity and inappropriate use.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0108026
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Biological Abstracts
- Chemical Abstracts
- Excerpta Medica
- Index Medicus